SNC
ACHV icon

Stifel Nicolaus & Co’s Achieve Life Sciences ACHV Stock Holding History

Stifel Nicolaus & Co’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$113K Buy
+6
New +$124K ﹤0.01% 1428

Other funds holding ACHV

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Stifel Nicolaus & Co's ACHV Position: Q3 2013 in Review

Stifel Nicolaus & Co opened a new position in Achieve Life Sciences (ACHV) in Q3 2013: 6 shares worth $113K. The stake represents ﹤0.01% of the portfolio and ranks #1428 among its holdings.

58 funds tracked by Wall St. Rank hold ACHV as of Q3 2013.

  • Stifel Nicolaus & Co held 6 shares of Achieve Life Sciences worth $113K as of Q3 2013.
  • Achieve Life Sciences was a new Stifel Nicolaus & Co position in Q3 2013.
  • Achieve Life Sciences made up ﹤0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #1428 holding.
  • 58 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.